All In Biotech

Drug Trial Radar · NCT05627375

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

Last checked: Nov 20, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,400

Planned (sponsor's estimate)

Start

Aug 16, 2023

Primary completion

Dec 2027

Study completion Dec 2028

Sponsor

Lead sponsor
Centre Hospitalier Universitaire de Saint EtienneAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ministry of Health, France
First posted
Nov 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Venous thromboembolism (VTE) and atherosclerotic cardiovascular disease share common risk factors and frequently coexist in the same patients. Their management requires use of antithrombotic agents: anticoagulant therapy (AC) for secondary prevention of VTE recurrence, antiplatelet (AP) for secondary prevention of major adverse ischemic cardiovascular and cerebrovascular event (MACCE) in patients with atherosclerotic cardiovascular disease (coronary artery disease, atherosclerotic cerebrovascular disease, lower extremity peripheral arterial disease). Side effects of antithrombotic drugs are the 1st cause of emergency admission and hospitalization for an adverse drug reaction (mainly bleeding), and the combination of AC with AP strongly increases this risk.

Conditions

  • Venous Thromboembolic Disease

Interventions

  • Full-dose anticoagulant therapy (AC)Drug

    Anticoagulant (AC) therapy: at the investigator's discretion in accordance with international recommendations for the management of DVT/PE

  • Antiplatelet therapy (AP)Drug

    Aspirin (at a daily dose ≤100 mg) or Clopidogrel (at a daily dose ≤75mg)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinically relevant bleedingTime frame: end of the full-dose treatment period, up to 12 months

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Amiens

    Amiens, France · Recruiting

  • CHU Angers

    Angers, France · Recruiting

  • CHU Besançon - Hôpital Jean Minjoz

    Besançon, France · Recruiting

  • CHRU Brest - Hôpital la Cavale Blanche

    Brest, France · Recruiting

  • Clinique du Parc - Castelnau-le -lez

    Castelnau-le-Lez, France · Recruiting

  • CHU Clermont-Ferrand - Hôpital Gabriel Montpied

    Clermont-Ferrand, France · Recruiting

  • CHU Dijon

    Dijon, France · Recruiting

  • CH le Corbusier - Firminy

    Firminy, France · Recruiting

  • CHU Grenoble - Hôpital la Tronche

    Grenoble, France · Recruiting

  • CH Le Puy - Hôpital Emile Roux

    Le Puy-en-Velay, France · Recruiting

  • CHU Limoges

    Limoges, France · Recruiting

  • HCL - Hôpital Edouard Herriot

    Lyon, France · Recruiting

  • HCL - Lyon Sud

    Lyon, France · Recruiting

  • APHM - Hôpital la Timone

    Marseille, France · Recruiting

  • CH du Forez - Montbrison

    Montbrison, France · Recruiting

  • CHU Montpellier

    Montpellier, France · Recruiting

  • CHU Nancy - Hôpitaux de Brabois

    Nancy, France · Recruiting

  • CHU Nantes - Hôpital Hôtel-Dieu

    Nantes, France · Recruiting

  • CHU de Nice - Hôpital Pasteur

    Nice, France · Recruiting

  • APHP - Hôpital Bicêtre

    Paris, France · Recruiting

  • APHP - Hôpital Européen Georges Pompidou HEGP

    Paris, France · Recruiting

  • APHP - Hôpital Louis Mourier

    Paris, France · Recruiting

  • CHU Rouen

    Rouen, France · Recruiting

  • CHU Saint-Etienne

    Saint-Etienne, France · Recruiting

  • CHU Strasbourg - Nouvel Hôpital Civil

    Strasbourg, France · Recruiting

  • CH Toulon - Hôpital Sainte Musse

    Toulon, France · Recruiting

  • CHU Toulouse - Hôpital de Rangueil

    Toulouse, France · Recruiting

  • CHU Tours

    Tours, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.